Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (391-400 of 422) with videos related to

Pageof 43
Sort By:
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2025
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysisKristina Vrotniakaite-Bajerciene, Ranjeeta Mallick, Toshihiko Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care SystemsAng Li, Jennifer La, Sarah B May, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis DayNicola Potere, Stefano Barco, Isabelle Mahé, et al.
Pageof 43

Showing results (391-400 of 422) with videos related to

Sort By:
Pageof 43
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2025
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysisKristina Vrotniakaite-Bajerciene, Ranjeeta Mallick, Toshihiko Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care SystemsAng Li, Jennifer La, Sarah B May, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Clinical Trials (London, England)|August 21, 2020
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2022
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis DayNicola Potere, Stefano Barco, Isabelle Mahé, et al.
Pageof 43